P53-specific T cell responses in patients with malignant and benign ovarian tumors: Implications for p53 based immunotherapy-Reference-Cited by-同舟云学术

P53-specific T cell responses in patients with malignant and benign ovarian tumors: Implications for p53 based immunotherapy

Published:2007 Issue:3 Volume:121 Page:606-614
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Lambeck Annechien,Leffers Ninke,Hoogeboom Baukje-Nynke,Sluiter Wim,Hamming Ineke,Klip Harry,ten Hoor Klaske,Esajas Martha,van Oven Magda,Drijfhout Jan-Wouter,Platteel Inge,Offringa Rienk,Hollema Harry,Melief Kees,van der Burg Sjoerd,van der Zee Ate,Daemen Toos,Nijman Hans

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference58 articles.

1. Cancer of the Ovary

2. Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer

3. Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines.

4. Study of HLA class I restriction and the directed antigens of cytotoxic T lymphocytes at the tumor sites of ovarian cancer

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein ubiquitination in ovarian cancer immunotherapy: The progress and therapeutic strategy;Genes & Diseases;2023-10

2. Mutated p53 in HGSC—From a Common Mutation to a Target for Therapy;Cancers;2021-07-10

3. Inflammation and immunity in ovarian cancer;European Journal of Cancer Supplements;2020-08

4. Natural Compounds with Potential to Modulate Cancer Therapies and Self-Reactive Immune Cells;Cancers;2020-03-13

5. p53, cancer and the immune response;Journal of Cell Science;2020-03-01